Tranexamic Acid for Intracerebral Hemorrhage in Patients on Non-Vitamin K Antagonist Oral Anticoagulants (TICH-NOAC): A Multicenter, Randomized, Placebo-Controlled, Phase 2 Trial

Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage - Sembill - 2020 - Annals of Clinical and Translational Neurology - Wiley Online Library

PDF) Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT

Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3 ): a randomised, placebo-controlled trial. - Abstract - Europe PMC

Interaction Between Participant Characteristics and Treatment Randomization

Significance of Intraventricular Hemorrhage in Acute Intracerebral Hemorrhage

PDF) Tranexamic Acid for Acute Spontaneous Intracerebral Hemorrhage: A Meta-Analysis of Randomized Controlled Trials

Brian Gilbert, PharmD, MBA, FCCM, FNCS on X: *from the rooftops* TXA is a narrow spectrum hemostatic agent. DOAC-associated ICH needs thrombin generation. I've never read anything that DOACs increase fibrinolysis so not sure why we put TXA in

PDF] Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH- 2): an international randomised, placebo-controlled, phase 3 superiority trial

2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

PDF) Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use

Use of direct oral anticoagulants in ICU patients. Part II – Clinical evidence

Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage - Eilertsen, H - 2023